Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr₹107 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹7,420 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr
Mar2021₹107 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr
57.15
Mar2021 ₹107 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹92,591.0 Cr -0.1% -8.3% -14% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,034.0 Cr 0.9% 5.3% 1.8% Stock Analytics
DIVIS LABORATORIES ₹169,211.0 Cr -2.3% -3.3% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,875.0 Cr -3.3% 2.8% 19.7% Stock Analytics
CIPLA ₹122,082.0 Cr -1.6% -9.2% 4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,873.0 Cr NA -3.5% 4.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.1%

-8.3%

-14%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses